African Journal of Microbiology Research
Subscribe to AJMR
Full Name*
Email Address*

Article Number - B30595965421

Vol.11(29), pp. 1150-1154 , August 2017
ISSN: 1996-0808

 Total Views: 0
 Downloaded: 0

Full Length Research Paper

Immunological evaluation of sequential poliovirus vaccination among Saudi and non-Saudi children living in Jeddah

Sana G. Alattas
  • Sana G. Alattas
  • 1Department of Biological Sciences, Faculty of Science, King Abdulaziz University (KAU) P. O. Box 4702, Jeddah 21412, Saudi Arabia.
  • Google Scholar

 Received: 06 May 2017  Accepted: 14 July 2017  Published: 07 August 2017

Copyright © 2017 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0

Poliomyelitis is a life-threatening acute paralytic disease caused by Poliovirus (PV). In the present study, the immunostatus of polio-vaccinated children and young adults (1 to 21 years old) living in Jeddah, Saudi Arabia was investigated to ascertain their extent of protection against the virus. Children were categorized in three groups: (A) Immunocompetent: Group I: Vaccinated by IPV at first and, Group II- Vaccinated by OPV at first; (B) Immunocompromised: Tuberculosis (T.B), diabetes, AIDS, congenital immunodeficiency; and (C) Control group: healthy children vaccinated at a private hospital in Jeddah- IMC hospital. Blood samples (692) were collected from the children admitted to Hospital children wards of King Abdulaziz University Hospital-KAUH (Government), and International Medical Center Hospital-IMC (Private) in Jeddah City, for routine medical examination checkup, during a 24-month period, from January 2015 to December 2016. A total of 228 (32.95%) were Saudis and 464 (67.05%) were non-Saudi individuals. The number of samples found to be negative for polio immunoglobulin G (IgG) and were considered as non-immune children was 72 (10.4%) while the overall immune responders were 584 (84.4%). 36 (5.2%) were low positive and their immunity against polio infection was doubtful. Non-Saudi seronegative subjects varied from 28 (6.03%) Yemani, 24 (5.17%) Somalian, 8 (1.72%) Afghani, 4 (0.86%) Indians, 3 (0.65%) Chadian, 2 (0.43%) Pakistanis; to 2 (0.43%) Nigerians. Based on the present data, we recommend higher vaccination coverage and sensitive surveillance investigation in polio-free countries. Evaluation of vaccination programmes should be carried out for the early detection of immune negative and disease-susceptible individuals.

Key words: Poliomyelitis, poliovirus vaccination, seronegative, immunization, immune response.

Bandyopadhyay AS, Garon J, Seib K, Orenstein WA (2015). Polio vaccination: past, present and future. Future Microbiol. 10:791-808.


Bodian D (1972). Poliomyelitis. In. Pathology of the Nervous System, Vol 3. Minckler (ed.). New York: McGraw-Hill, pp. 2323-2344.


Bodian D, Morgan I M, Howe HA (1949). Differentiation of types of poliomyelitis viruses. III. The grouping of fourteen strains into three basic immunological types. Am. J. Hyg. 49:234-245.


Brack M (1987). Agents Transmissible from Simians to Man. Berlin: Springer-Verlag.


Centers for disease Control and prevention (CDC) (2006). Resurgence of wild poliovirus type 1 transmission and consequences of importation-21 countries, 2002–2005. MMWR 55:145-150.


Centers for disease Control and prevention (CDC) (2001a). Circulation of a type 2 vaccine-derived poliovirus-Egypt, 1982–1993. Morbid. Mortal. Weekly Rep. 50:41-51.


Centers for disease Control and prevention (CDC) (2001b). Progress toward global eradication of poliomyelitis. Morbid. Mortal. Weekly Rep. 2002a. 51:253-256.


Certification of poliomyelitis eradication- European Region (2002). MMWR -Morb. Mortal. Weekly. Rep. 51:572-574.


Cheuk DKL (2007). New Childhood Immunisation Programme in Hong Kong. The Hong Kong Medical Diary 12(7):22-24.


Dhole TN, Ayyagari A, Chowdhary R, Shakya AK, Shrivastav N, Datta T, Prakash V (2009). Non-Polio Enteroviruses in acute flaccid paralysis children of India: Vital assessment before Polio eradication. J. Paediatr. Child Health 45:409-413.


Ertem M, Sarac A, Tumay S (2000). Poliomyelitis eradication programme: acute flaccid paralysis surveillance in Mardin and five other provinces around Mardin, Turkey 1998. Public Health 114:286-290.


Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL (1990). Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J. Infect. Dis. 162(6):1291-1297.


Fine EMP, Carneiro AM (1990). Transmissibility and persistence of oral polio vaccine viruses: Implications for the global poliomyelitis eradication initiative. Am. J. Epidemiol. 150:1011-1012.


Hovi T, Blomqvist S, Nasr E, Burns CC, Sarjakoski T, Ahmed N, Savolainen C, Roivainen M, Stenvik M, Laine P, Barakat I, Wahdan MH, Kamel FA, Asghar H, Pallansch MA, Kew OM, Gary HE Jr, de Gourville EM, El Bassioni L(2005). Environmental surveillance of wild poliovirus circulation in Egypt-balancing between Mugisha et al. Oral polio vaccination in captive chimpanzees detection sensitivity and workload. J. Virol. Methods 126:127-134.


Hovi T, Shulman LM, Vander Avoort H, Deshpande J, Ro Iva Inen M, De Gourville EM (2011). REVIEW ARTICLE Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol. Infect. Page 1 of 13. f Cambridge University Press and World Health Organization.


Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch M (2004) . Circulating vaccinederived polioviruses: current state of knowledge. Bull. World Health Organ. 82:16-32.


Lopez-Medina E, Melgar M, Gaensbauer JT, Bandyopadhyay AS, Borate BR, Weldon WC, Rüttimann R, Ward J, Clemens R, Asturias EJ (2017). Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America. Vaccine 35(28):3591-3597.


Moriniere BJ, van Loon FP, Rhodes PH, Klein-Zabban ML, Frank-Senat B, Herrington JE, Patriarca PA (1993). Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet 341:1545-1550.


Mugisha L, Pauli G, Opuda-Asibo J, Joseph OO, Leendertz FH, Diedrich S (2010). Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda. J. Med. Primatol. 39:123-128.


Nathanson N, Martin JR (1979). The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemiology, and disappearance. Am. J. Epidemiol. 110:672-691.


Patel M, Orenstein WA (2016). A World free of polio – the final steps. N. Engl. J. Med. 374:501-503.


Patriarca PA, Wright PF, John TJ (1991). Factors affecting immunogenicity of oral polio vaccine in developing countries: A review. Rev. Infect. Dis. 13:926-939.


Pelczar MJ Jr, Chan ECS, Krieg NR (1993). Microbiology: Concepts and Applications. McGraw-Hill, Inc., New York. 698.


Platt LR, Estívariz CF, Sutter RW (2014). Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden. Epidemiology and Global Burden of VAPP. J. Infect. Dis. 210(suppl_1):S380- S389.


Progress toward interruption of wild poliovirus transmission--Worldwide January 2005-March 2006 (2006). MMWR Morb. Mortal Wkly. Rep. 55(16):458-462.


Saleem AF, Mach O, Yousafzai MT, Khan A, Weldon WC, Oberste MS, Sutter RW, Zaidi AKM (2014). Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan. Vaccine 35(24):3209-3214.


Tafuri S, Prato R, Martinelli D, Calvario A, Bozzi A, Labianca M, Patti A, Lopalco PL, Germinario C (2008). Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy). BMC Infect. Dis. 8(1):150.


Tao Z, Zhang Y, Liu Y, Xu A, Lin X, Yoshida H, Xiong P, Zhu S, Wang S, Yan D, Song L,Wang H, Cui N, Xu W(2013). Isolation and Characterization of a Type 2 Vaccine-Derived Poliovirus from Environmental Surveillance in China, 2012. PloS One 8(12):e83975.


Tao Z, Wang Z, Lin X, Wang S, Wang H, Yoshida H, Xu A, Song Y (2016). One-year Survey of human enteroviruses from sewage and the factors affecting virus adsorption to the suspended solids. Sci. Rep. 6:31474.


The annual statistics book of health (2004). Ankara, Turkey: The Republic of Turkey Ministry of Health. P 68.


Thompson KM, Duintjer Tebbens RJ, Pallansch MA (2006). Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Anal. 26:1541-1556.


Vancelik S, Guraksin A, Ayyildiz A, and Beyhun N E (2007). Seroepidemiology of poliovirus antibody among the children in Eastern Turkey. Indian J. Med. Res. 126:528-533.


World Health Organization (WHO) (2004). Polio eradication initiative. Office of the Director-General and Department of Immunization, Vaccines and Biologicals, Family and Community Health. The Global Polio Eradication Initiative Strategic Plan 2004-2008. WHO: Geneva.


World Health Organization (WHO) (2013). Global Polio Eradication Initiative. Polio Eradication & Endgame Strategic Plan 2013-2018. Geneva, Switzerland: World Health Organization (2013). 


APA Alattas, S. G. (2017). Immunological evaluation of sequential poliovirus vaccination among Saudi and non-Saudi children living in Jeddah. African Journal of Microbiology Research, 11(29), 1150-1154.
Chicago Sana G. Alattas, . "Immunological evaluation of sequential poliovirus vaccination among Saudi and non-Saudi children living in Jeddah." African Journal of Microbiology Research 11, no. 29 (2017): 1150-1154.
MLA Sana G. Alattas, . "Immunological evaluation of sequential poliovirus vaccination among Saudi and non-Saudi children living in Jeddah." African Journal of Microbiology Research 11.29 (2017): 1150-1154.

Subscription Form